Vanda Pharmaceuticals Reports Second Quarter 2024 Financial Results
Go back to Vanda Pharmaceuticals Reports Second Quarter 2024 Financial Results| Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) | Delayed: 6.39 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.39 | 52 Week High | $18.00 | |||
| Open | $6.39 | 52 Week Low | $6.91 | |||
| Day High | $6.39 | P/E | N/A | |||
| Day Low | $6.39 | EPS | $-0.67 | |||
| Volume | 469 | |||||

